Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy

Introduction: The addition of durvalumab after chemoradiation therapy (CRT) in unresectable stage III NSCLC significantly improves survival. The benefit of this approach in elderly patients is controversial given the toxicity associated with CRT and, thus, may be underutilized. We sought to investig...

書目詳細資料
發表在:	JTO Clinical and Research Reports
Main Authors:	Sally C.M. Lau, MD, MPH, Malcolm Ryan, BSc, Jessica Weiss, PhD, Aline Fusco Fares, MD, Miguel Garcia, MD, Sabine Schmid, MD, Shelley Kuang, MD, Deirdre Kelly, MB BCh BAO, Ming Sound Tsao, MD, Penelope A. Bradbury, MB BCh, Byoung Chun J. Cho, MD, Alexander Sun, MD, Srinivas Raman, MD, Andrew Hope, MD, Meredith Giuliani, MBBS, MEd, PhD, Benjamin H. Lok, MD, PhD, Andrea Bezjak, MD, Geoffrey Liu, MD, MSc, Natasha B. Leighl, MD, MSc, Frances A. Shepherd, MD, Adrian G. Sacher, MD, MMSc
格式:	Article
語言:	英语
出版:	Elsevier 2021-12-01
主題:	Elderly Chemoradiotherapy Immune checkpoint inhibitors Multimodality treatment Safety
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2666364321001107

相似書籍

High-Grade Pneumonitis Events in Patients With Unresectable, Locally Advanced NSCLC Treated With Definitive Chemoradiation Followed by Adjuvant Durvalumab
由: Ciani Ellison, MD, et al.
出版: (2024-12-01)

Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC
由: Johan F. Vansteenkiste, MD, PhD, et al.
出版: (2024-03-01)

Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18
由: Dae-Ho Choi, MD, et al.
出版: (2024-12-01)

Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer
由: Rishi Das, MD, MPH, et al.
出版: (2023-11-01)

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC
由: Yuhei Kinehara, MD, PhD, et al.
出版: (2023-11-01)

Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLC
由: Tomoki Kuge, MD, et al.
出版: (2023-05-01)

Real-World Pharmacokinetics, Effectiveness, and Safety of Atezolizumab in Patients With Unresectable Advanced or Recurrent NSCLC: An Exploratory Study of J-TAIL
由: Shigehiro Yagishita, MD, PhD, et al.
出版: (2024-07-01)

Clinical Outcomes and Safety of Concurrent Chemoradiotherapy in EGFR-Mutant Unresectable Stage III NSCLC
由: Shinkichi Takamori, MD, PhD, et al.
出版: (2026-04-01)

Turtle Study: A Phase 2 Study of Durvalumab Plus Carboplatin and Etoposide in Elderly Patients With Extensive-Stage SCLC (LOGiK 2003)
由: Hidenobu Ishii, MD, PhD, et al.
出版: (2025-07-01)

Durvalumab Plus Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARD
由: Byoung Chul Cho, MD, PhD, et al.
出版: (2026-04-01)

Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report
由: Yuanbin Chen, MD, PhD, et al.
出版: (2022-06-01)

Atezolizumab plus bevacizumab-induced intratumoral hemorrhage in a patient with rib metastasis from unresectable hepatocellular carcinoma
由: Yasuhito Mitsuyama, MD, et al.
出版: (2023-09-01)

Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma
由: Ryu Sasaki, MD, PhD, et al.
出版: (2022-05-01)

Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC
由: Wang Jing, MD, et al.
出版: (2022-09-01)

Effectiveness and Safety of Atezolizumab Monotherapy in Previously Treated Japanese Patients With Unresectable Advanced or Recurrent NSCLC: A Multicenter, Prospective, Observational Study (J-TAIL)
由: Satoru Miura, MD, PhD, et al.
出版: (2023-03-01)

Durvalumab With or Without Tremelimumab in Combination With Chemoradiotherapy in Patients With Limited-Stage SCLC: Results from the Phase 1 CLOVER Study
由: Byoung Chul Cho, MD, PhD, et al.
出版: (2025-10-01)

Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer
由: Stephen R. Bowen, PhD, et al.
出版: (2022-03-01)

Clinical Outcomes of Proton Beam Therapy for Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Retrospective Study
由: Ichiro Seto, MD, DMD, PhD, et al.
出版: (2024-10-01)

Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
由: Binkui Li, MD, PhD, et al.
出版: (2021-06-01)

Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis
由: Kelsey L. Corrigan, MD, MPH, et al.
出版: (2022-07-01)

Chinese Herbal Medicine for Concurrent Chemoradiation-Induced Adverse Events in Head and Neck Cancer Patients: A Prospective Feasibility Study
由: Hsuan-Ting Tang MD, et al.
出版: (2025-03-01)

Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies
由: Sally C.M. Lau, MD, MPH, et al.
出版: (2023-10-01)

PC2. Targeted Greening Measures to Reduce Waste in Outpatient Hand Surgery
由: Ruth Tevlin, MB, BAO BCh, MRCSI, MD, et al.
出版: (2023-04-01)

Tocilizumab for Steroid Pulse-Refractory Cytokine Release Syndrome in Chemotherapy With Durvalumab Plus Tremelimumab for NSCLC: A Case Report
由: Ken Yamamoto, MD, et al.
出版: (2025-09-01)

The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment
由: Nina J. Wesdorp, MD, et al.
出版: (2021-12-01)

Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial
由: Karen Bolhuis, MD, et al.
出版: (2021-09-01)

Outcomes and Toxicities of Definitive Radiation Therapy for Unresected Thymic Malignancies
由: Sana Raoof, MD, PhD, et al.
出版: (2026-05-01)

Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases
由: Matthew Ramotar, HBSc, et al.
出版: (2020-05-01)

Sweet syndrome in a patient with rectal adenocarcinoma and HIV following neoadjuvant chemoradiation
由: Kamina Wilkerson, BS, et al.
出版: (2024-01-01)

Durvalumab-induced organizing pneumonia in extensive-stage small cell lung cancer: A case report and literature review
由: Guoxin Wang, MD, et al.
出版: (2025-05-01)

Endoscopy esophageal mucosal circumferential resection followed by bypass surgery to treat tracheoesophageal fistulaCentral MessagePerspective
由: Chunguang Li, MD, PhD, et al.
出版: (2025-10-01)

Epiphyseal osteoid osteoma of the proximal tibial epiphysis treated by CT-guided radiofrequency ablation: A case report
由: Mohamed Elsayed Elnaggar, MB BCh, MSc, EDIR, et al.
出版: (2023-08-01)

Transfusion Risk Factors in Low-Energy Pelvic Fractures: A Retrospective Cohort Study
由: Hieronim Kołodziejczyk MD, et al.
出版: (2025-06-01)

Arteriosus Jugular Arch in a Cadaveric Specimen
由: George K. Paraskevas MD, MSc, PhD, et al.
出版: (2024-08-01)

Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach
由: Michail Nikolaou MD, MSc, PhD, et al.
出版: (2019-01-01)

Primary Inverted Papilloma of the Middle Ear
由: Sarantis Blioskas MD, PhD, et al.
出版: (2024-06-01)

Revealing Etiology of Heart Failure - Cardiac Manifestation of Systemic Sclerosis
由: Csilla Czimbalmos, MD, PhD, et al.
出版: (2024-01-01)

Long-Term Patient-Reported Dyspareunia After Definitive Chemoradiation for Anal Cancer: Using the Anterior Vaginal Wall as an Organ-at-Risk to Define an Actionable Dosimetric Goal
由: Michael K. Rooney, MD, et al.
出版: (2024-05-01)

Robotic transgastric local resection of endoscopically unresectable gastroesophageal junction benign/low-grade lesionsCentral Message
由: Yahya Alwatari, MB, BCh, BAO, et al.
出版: (2026-06-01)

Evaluation of Efficacy and Tolerance of Radical Radiotherapy and Radiochemotherapy in Treatment of Locally Advanced, Unresectable Rectal Cancer
由: M. Kraszkiewicz PhD, et al.
出版: (2022-03-01)